Jun 15, 2019 6:00am EDT Sutro Biopharma Announces Encouraging Interim Phase 1 Safety Data on a Potential First-in-Class Antibody-Drug Conjugate STRO-001 for the Treatment of B-cell Malignancies at the European Hematology Association Congress
May 16, 2019 9:02am EDT Sutro Biopharma Announces Presentation at the 2019 European Hematology Association Congress
May 15, 2019 7:00am EDT Sutro Biopharma Reports First Quarter 2019 Financial Results and Recent Business Highlights and Developments
Apr 01, 2019 5:00am EDT Sutro Biopharma Reports Full Year 2018 Financial Results and Recent Business Highlights and Developments
Mar 15, 2019 7:00am EDT Sutro Biopharma Initiates Phase I Clinical Trial of STRO-002 for the Treatment of Ovarian and Endometrial Cancers
Mar 05, 2019 7:00am EST Sutro Biopharma to Present at the Cowen and Company 39th Annual Health Care Conference
Jan 29, 2019 7:00am EST Sutro Biopharma Expands Leadership Team with Appointment of Vice President of Chemistry